Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.
Rybinski K, Imtiyaz HZ, Mittica B, Drozdowski B, Fulmer J, Furuuchi K, Fernando S, Henry M, Chao Q, Kline B, Albone E, Wustner J, Lin J, Nicolaides NC, Grasso L, Zhou Y.
Rybinski K, et al. Among authors: wustner j.
Oncotarget. 2015 Sep 22;6(28):25429-40. doi: 10.18632/oncotarget.4559.
Oncotarget. 2015.
PMID: 26327620
Free PMC article.